Zomedica Corp. Files 8-K on Shareholder Votes and Financials
Ticker: ZOMDF · Form: 8-K · Filed: Jun 7, 2024 · CIK: 1684144
| Field | Detail |
|---|---|
| Company | Zomedica Corp. (ZOMDF) |
| Form Type | 8-K |
| Filed Date | Jun 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting
TL;DR
Zomedica filed an 8-K for shareholder votes & financials as of June 6.
AI Summary
Zomedica Corp. filed an 8-K on June 7, 2024, reporting on matters submitted to a vote of security holders and financial statements. The filing covers events as of June 6, 2024, and includes information about the company's principal executive offices in Ann Arbor, Michigan.
Why It Matters
This filing provides updates on Zomedica's corporate governance and financial reporting, which are crucial for investors to assess the company's operational status and strategic direction.
Risk Assessment
Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate operational or financial distress.
Key Players & Entities
- Zomedica Corp. (company) — Registrant
- June 6, 2024 (date) — Earliest event reported
- June 7, 2024 (date) — Filing date
- Ann Arbor, Michigan (location) — Principal executive offices
FAQ
What specific matters were submitted to a vote of Zomedica Corp. security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the primary business of Zomedica Corp. based on its SIC code?
Zomedica Corp.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
When was Zomedica Corp. incorporated or organized?
Zomedica Corp. was incorporated in Alberta, Canada.
What is the address of Zomedica Corp.'s principal executive offices?
The principal executive offices of Zomedica Corp. are located at 100 Phoenix Drive, Suite 125, Ann Arbor, Michigan 48108.
What is the SEC file number for Zomedica Corp.?
The SEC file number for Zomedica Corp. is 001-38298.
Filing Stats: 672 words · 3 min read · ~2 pages · Grade level 13.8 · Accepted 2024-06-07 15:54:32
Filing Documents
- zom_8k.htm (8-K) — 39KB
- 0001654954-24-007515.txt ( ) — 158KB
- zom-20240606.xsd (EX-101.SCH) — 6KB
- zom-20240606_lab.xml (EX-101.LAB) — 14KB
- zom-20240606_cal.xml (EX-101.CAL) — 1KB
- zom-20240606_pre.xml (EX-101.PRE) — 9KB
- zom-20240606_def.xml (EX-101.DEF) — 2KB
- zom_8k_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. An annual meeting of our shareholders was held on June 6, 2024 (the "Annual Meeting"). At the Annual Meeting, our shareholders voted on each of the following three matters: Proposal 1: Election of eight directors, each for a one-year term; Proposal 2: Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2024; and Proposal 3: An advisory vote to approve the compensation of our named executive officers as described in our management information circular and proxy statement for the Annual Meeting. According to the final vote, the Company's stockholders approved proposals 1 and 2 and did not approve proposal 3. The final vote results for each of these four matters is set forth below. Proposal 1 : Election of Eight Directors For Withheld Broker Non-Vote Jeffrey Rowe 110,760,471 61,531,927 183,131,920 Robert Cohen 104,897,697 67,394,701 183,131,920 Chris Macleod 110,762,680 61,529,718 183,131,920 Pam Nichols 113,970,507 58,321,891 183,131,920 Johnny D. Powers 117,642,702 54,649,696 183,131,920 Sean Whelan 110,747,785 61,544,613 183,131,920 Rodney Williams 110,993,136 61,299,262 183,131,920 Larry Heaton 103,625,393 68,667,005 183,131,920 Accordingly, stockholders elected all director nominees to hold office for terms expiring at the Company's 2025 annual meeting of stockholders. Proposal 2 : Ratification of Independent Auditors For: 288,330,513 Withheld: 67,093,805 Total: 355,424,318 Accordingly, stockholders ratified the appointment of Grant Thornton, LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2023. Proposal 3: Advisory Vote on the Company's Executive Compensation The votes cast on the advisory vote to approve the compensation of our named executive officers disclosed in our management information circular and proxy statement for the Annua
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Zomedica Corp. By: /s/ Peter Donato Peter Donato Chief Financial Officer Date: June 7, 2024 3